16.82
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$16.08
Offen:
$16.17
24-Stunden-Volumen:
27.57M
Relative Volume:
1.05
Marktkapitalisierung:
$32.28B
Einnahmen:
$15.14B
Nettoeinkommen (Verlust:
$1.42B
KGV:
22.86
EPS:
0.7361
Netto-Cashflow:
$1.63B
1W Leistung:
+6.77%
1M Leistung:
-10.99%
6M Leistung:
-22.89%
1J Leistung:
-21.99%
Kenvue Inc Stock (KVUE) Company Profile
Firmenname
Kenvue Inc
Sektor
Telefon
908-874-1200
Adresse
1 KENVUE WAY, SUMMIT
Vergleichen Sie KVUE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
KVUE
Kenvue Inc
|
16.82 | 30.86B | 15.14B | 1.42B | 1.63B | 0.7361 |
![]()
PG
Procter Gamble Co
|
150.68 | 352.69B | 84.28B | 16.07B | 14.05B | 6.5067 |
![]()
UL
Unilever Plc Adr
|
59.00 | 143.78B | 64.99B | 6.71B | 6.53B | 2.4355 |
![]()
CL
Colgate Palmolive Co
|
78.06 | 63.04B | 20.00B | 3.05B | 3.37B | 3.5578 |
![]()
KMB
Kimberly Clark Corp
|
120.00 | 39.69B | 18.88B | 2.38B | 2.10B | 7.2549 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
2025-04-10 | Eingeleitet | Redburn Atlantic | Neutral |
2025-03-24 | Eingeleitet | Evercore ISI | In-line |
2025-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
2024-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
2024-09-24 | Eingeleitet | Jefferies | Buy |
2024-09-24 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2024-05-28 | Fortgesetzt | Citigroup | Neutral |
2024-04-11 | Eingeleitet | Bernstein | Underperform |
2024-04-03 | Eingeleitet | William Blair | Mkt Perform |
2024-03-01 | Fortgesetzt | Goldman | Neutral |
2023-11-17 | Eingeleitet | Piper Sandler | Neutral |
2023-09-11 | Hochstufung | Deutsche Bank | Hold → Buy |
2023-09-07 | Eingeleitet | Canaccord Genuity | Buy |
2023-09-06 | Eingeleitet | Argus | Hold |
2023-08-24 | Hochstufung | Goldman | Neutral → Buy |
2023-07-25 | Eingeleitet | Edward Jones | Buy |
2023-06-01 | Eingeleitet | HSBC Securities | Hold |
2023-05-30 | Eingeleitet | BofA Securities | Buy |
2023-05-30 | Eingeleitet | Citigroup | Neutral |
2023-05-30 | Eingeleitet | Deutsche Bank | Hold |
2023-05-30 | Eingeleitet | Exane BNP Paribas | Neutral |
2023-05-30 | Eingeleitet | Goldman | Neutral |
2023-05-30 | Eingeleitet | JP Morgan | Overweight |
2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-05-30 | Eingeleitet | UBS | Neutral |
Alle ansehen
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
November 28th Options Now Available For Kenvue (KVUE) - Nasdaq
Is Kenvue Inc. stock a buy in volatile marketsEntry Point & Daily Oversold Bounce Ideas - newser.com
Chart based analysis of Kenvue Inc. trends2025 Valuation Update & Precise Buy Zone Tips - newser.com
Is Kenvue Inc. (J4D) stock a buy for dividend portfoliosStock Surge & Weekly High Return Stock Opportunities - newser.com
Kenvue Inc. $KVUE Shares Sold by Belpointe Asset Management LLC - MarketBeat
Comparing Kenvue Inc. in custom built stock radarsDay Trade & Free Verified High Yield Trade Plans - newser.com
Is Kenvue Inc. a candidate for recovery play2025 Price Targets & Weekly High Return Opportunities - newser.com
QRG Capital Management Inc. Buys 29,813 Shares of Kenvue Inc. $KVUE - MarketBeat
Donald Trump’s Tylenol Warning Makes Kenvue Stock (KVUE) an Opportunity in Disguise - TipRanks
Kenvue (KVUE): Exploring Valuation After Recent Share Price Weakness - Yahoo Finance
Kenvue’s SWOT analysis: stock faces Tylenol headwinds amid strategic shift - Investing.com
Kenvue’s SWOT analysis: stock faces Tylenol headwinds amid strategic shift By Investing.com - Investing.com UK
Kenvue (NYSE:KVUE) Price Target Lowered to $21.00 at Bank of America - MarketBeat
Moderately bullish activity in Kenvue Inc with shares down 0.59% - TipRanks
Kenvue Becomes Oversold - Nasdaq
How the Narrative Around Kenvue Is Shifting Amid Legal and Regulatory Headwinds - Yahoo Finance
UBS Adjusts Kenvue Price Target to $17 From $23, Maintains Neutral Rating - MarketScreener
Kenvue price target lowered to $17 from $23 at UBS - TipRanks
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump - The Motley Fool
Citigroup Adjusts Price Target on Kenvue to $17 From $20, Maintains Neutral Rating - MarketScreener
WESPAC Advisors LLC Invests $544,000 in Kenvue Inc. $KVUE - MarketBeat
Near 52-Week Low, Should You Buy Kenvue Stock? - The Globe and Mail
KLP Kapitalforvaltning AS Has $22.45 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Simplicity Wealth LLC Purchases Shares of 24,210 Kenvue Inc. $KVUE - MarketBeat
Did Trump’s Tylenol Pregnancy Warning Just Shift Kenvue's (KVUE) Brand Risk Profile? - simplywall.st
Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks - MSN
Bullish flow in Kenvue Inc with shares up 3.22% - TipRanks
Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again - Sahm
Is Kenvue Inc. stock a buy before new product rolloutJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Visual trend scoring systems applied to Kenvue Inc.Stop Loss & AI Driven Price Forecasts - newser.com
Kenvue Inc. $KVUE Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Why Is Kenvue Stock Falling, and Is It a Buying Opportunity? - The Motley Fool
What insider purchases suggest about Kenvue Inc. stockMarket Performance Summary & AI Powered Market Trend Analysis - newser.com
How strong is Kenvue Inc. stock earnings growth2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
Why retail traders accumulate Kenvue Inc. stockJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
Will Kenvue Inc. stock outperform benchmarksTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Why analysts raise outlook for Kenvue Inc. (J4D) stockEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Why millennials buy Kenvue Inc. stockMarket Trend Review & Reliable Entry Point Alerts - newser.com
Litigation risks for Kenvue: focus shifts to U.S. appeals court - Investing.com
Is Kenvue Inc. stock near bottom after decline2025 Fundamental Recap & Real-Time Market Sentiment Alerts - newser.com
Assessing Kenvue (KVUE) Valuation: Is the Stock Priced for a Potential Turnaround? - simplywall.st
Market Movers: Metsera and Apple surge, Kenvue falters on Tylenol troubles - MSN
Truist Financial Corp Has $16.46 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Moody’s changes Kenvue outlook to negative amid operational challenges - Investing.com
Is Kenvue Inc. stock poised for growthTrend Reversal & AI Enhanced Execution Alerts - newser.com
Lawmakers dump Tylenol stock before autism controversy - Vermont Daily Chronicle
Goldman Sachs Sticks To Its Hold Rating For Kenvue, Inc. (KVUE) - Barchart.com
How Kenvue Inc. (J4D) stock performs in easing cycles2025 Short Interest & Real-Time Volume Triggers - newser.com
Barclays Lowers PT on Kenvue (KVUE) to $17 From $20, Keeps an Equal Weight Rating - Yahoo Finance
Is Kenvue Inc. stock among top earnings playsTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Is There an Opportunity in Kenvue After Recent 24% Share Price Drop? - simplywall.st
Finanzdaten der Kenvue Inc-Aktie (KVUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):